Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

A blood pressure drug, diltiazem, may also help treat influenza.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Some drugs for inflammation may cause psoriasis-like hair loss.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

PRP injections significantly improve hair regrowth in alopecia areata.

Infliximab successfully treated a severe hair loss case in Sri Lanka.

Combination therapy is more effective for prostate volumes over 60 ml.

TGF-β inhibitors may help treat liver fibrosis by targeting various pathways.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Cepharanthine may help treat lung fibrosis by affecting certain immune cells.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

PEA reduces pain by increasing neurosteroid synthesis in the spinal cord.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

CS12192 effectively treats alopecia areata with better safety than current options.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.